Suppr超能文献

选择性多巴胺 D-2 激动剂的长期给药:决定行为耐受性和敏化的因素。

Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization.

作者信息

Martin-Iverson M T, Stahl S M, Iversen S D

机构信息

Merck Sharpe & Dohme Neuroscience Research Centre, Harlow, Essex, UK.

出版信息

Psychopharmacology (Berl). 1988;95(4):534-9. doi: 10.1007/BF00172969.

Abstract

The locomotor stimulant effects of sustained administration of a potent and selective dopamine (DA) D-2 receptor agonist, [+]-4-propyl-9-hydroxynaphthoxazine (PHNO), in rats were assessed 24 h a day during 12 h light-dark cycles. PHNO was administered continuously with subcutaneous implants of Alzet osmotic minipumps (5 micrograms/h), for 12 h a day with modified osmotic minipumps (5 micrograms/h), or by daily injections (15 micrograms, SC). Tolerance was observed to occur only with 24 h continuous infusions and only during the light period. The other treatment regimens produced sensitization of the locomotor response. Daytime tolerance to continuous infusions of PHNO was reversed following reversal of the light-dark cycle. A normally 'arousing' stimulus also reversed (temporarily) daytime tolerance. The present results indicate that the temporal pattern of administration of DA agonists, the phase of the circadian cycle and environmental stimuli associated with arousal are important determinants of the behavioral consequences of long-term treatment.

摘要

在12小时明暗周期内,每天24小时评估持续给予强效选择性多巴胺(DA)D-2受体激动剂[+]-4-丙基-9-羟基萘并恶嗪(PHNO)对大鼠的运动刺激作用。PHNO通过皮下植入Alzet渗透微型泵(5微克/小时)持续给药,每天12小时使用改良渗透微型泵(5微克/小时)给药,或每日注射(15微克,皮下注射)。仅在24小时持续输注且仅在光照期观察到耐受性。其他治疗方案产生运动反应的敏化。昼夜节律周期逆转后,白天对持续输注PHNO的耐受性逆转。一种通常“唤醒”的刺激也(暂时)逆转了白天的耐受性。目前的结果表明,DA激动剂的给药时间模式、昼夜节律周期的阶段以及与唤醒相关的环境刺激是长期治疗行为后果的重要决定因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验